Ultragenyx Pharmaceutical Inc.
2019 Q4 - 2025 Q4 (15 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 14,797 | 0.1% | 643,356 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 14,516 | 0.0% | 482,582 | 9/30/2025 |
| 2024 Q3 | 11/14/2024 | 2,903 | 0.0% | 52,266 | 9/30/2024 |
| 2023 Q2 | 8/14/2023 | 878 | 0.0% | 19,027 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 4,831 | 0.0% | 120,474 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 3,977 | 0.0% | 85,834 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 733 | 0.0% | 17,695 | 9/30/2022 |
| 2022 Q1 | 5/16/2022 | 1,910 | 0.0% | 26,295 | 3/31/2022 |
| 2021 Q4 | 2/14/2022 | 4,021 | 0.0% | 47,816 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 1,060 | 0.0% | 11,754 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 2,713 | 0.0% | 28,456 | 6/30/2021 |
| 2021 Q1 | 5/17/2021 | 524 | 0.0% | 4,602 | 3/31/2021 |
| 2020 Q4 | 2/16/2021 | 1,604 | 0.0% | 11,585 | 12/31/2020 |
| 2020 Q3 | 11/16/2020 | 878 | 0.0% | 10,681 | 9/30/2020 |
| 2019 Q4 | 2/14/2020 | 924 | 0.0% | 21,635 | 12/31/2019 |